GlaxoSmithKline
GSK
#183
Rank
$86.03 B
Marketcap
$42.34
Share price
-0.09%
Change (1 day)
23.55%
Change (1 year)

Earnings for GlaxoSmithKline (GSK)

Earnings in 2023 (TTM): $9.02 B

According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $9.02 B. In 2022 the company made an earning of $6.93 B an increase over its 2021 earnings that were of $6.12 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for GlaxoSmithKline from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$9.02 B30.03%
2022$6.93 B13.36%
2021$6.12 B-30.36%
2020$8.79 B10.81%
2019$7.93 B25.28%
2018$6.33 B37.91%
2017$4.59 B80.02%
2016$2.55 B-83.68%
2015$15.63 B219.06%
2014$4.89 B-53.64%
2013$10.56 B-0.27%
2012$10.59 B-13.03%
2011$12.18 B149.01%
2010$4.89 B-60.81%
2009$12.48 B2.43%
2008$12.19 B-19.37%
2007$15.12 B4.68%
2006$14.44 B19.81%
2005$12.05 B5.67%
2004$11.40 B12.04%
2003$10.18 B45.8%
2002$6.98 B-9.52%
2001$7.71 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$9.43 B 4.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$12.25 B 35.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.11 B 45.38%๐Ÿ‡ซ๐Ÿ‡ท France
$8.51 B-5.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.49 B-5.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.40 B-95.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$68.79 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA